Integrative medicine for lymphoma survivors
Effectiveness of Integrative Medicine Treatments in Lymphoma Survivors
NA · Bnai Zion Medical Center · NCT05982223
This study tests if combining traditional treatments with therapies like acupuncture and mind-body practices can help lymphoma survivors feel better and improve their quality of life after treatment.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Bnai Zion Medical Center (other gov) |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Haifa) |
| Trial ID | NCT05982223 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of integrative treatments, combining conventional and complementary medicine, on the quality of life of lymphoma survivors. It focuses on patients who have undergone chemotherapy or biological treatments and are experiencing lingering symptoms and quality-of-life impairments. The interventions include acupuncture, mind-body therapy, touch therapy, movement therapy, and herbal supplements. The goal is to assess whether these integrative approaches can alleviate symptoms and improve overall well-being in this patient population.
Who should consider this trial
Good fit: Ideal candidates for this study are lymphoma survivors aged 18 and older who have completed chemotherapy or biological treatment and are in remission for less than one year.
Not a fit: Patients who are not lymphoma survivors or those who have been in remission for over a year may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly enhance the quality of life for lymphoma survivors by providing effective symptom relief and support.
How similar studies have performed: While many studies have shown success in using complementary medicine for breast cancer survivors, few have specifically examined its impact on lymphoma survivors, making this approach relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with a lymphoproliferative disease * Aged 18 years or older * Received chemotherapy, biological treatment or both for treating the lymphoproliferative disease * Defined in remission for less than one year by the haemato-oncologist (maintenance therapy is authorized) * Can respond to questionnaires * Signed informed consent Exclusion Criteria: None
Where this trial is running
Haifa
- Bnai Zion Medical Center — Haifa, Israel (RECRUITING)
Study contacts
- Principal investigator: Ilana Levy Yurkovski, MD — Bnai Zion Medical Center
- Study coordinator: Dana Weizer
- Email: dana.weizer@b-zion.org.il
- Phone: 972-543295952
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Lymphoma, Lymphoma survivors, Integrative medicine, Complementary medicine, Quality of life, Shiatsu, Acupuncture, Hematology